Introduction
============

In recent years, nonviral gene delivery system was widely used in gene delivery due to no or little risk of immune response and large-scale manufacturing compared with viral gene carriers ([@b8]; [@b9]).

[@b10] showed that the development of nanoparticles by stepwise layer-by-layer deposition of alternatively charged polyelectrolyte onto polystyrene and melamine formaldehyde latex particles that are able to encapsulate different pharmacological agents, proteins, and so on. Based on their studies, [@b14] made some compact particles with negative charge and low aggregation capacity under physiological conditions for nonviral gene delivery systems by depositing polyanion (PVS or transfer RNA) to DNA/polyethylenimine (PEI) complex. This approach was firstly used for DNA encapsulation with a DNA/poly-L-lysine (PL L) core by [@b11], in which PLL and succinylated PLL as polycation and polyanion, respectively, was used to deposit alternating layer of polyanion and polycation on the surface of positive DNA/PLL complex. These complexes with layer of alternating layer of polyanion and polycation was physicochemically characterized. Transfection activity of these complexes was shown by these authors later ([@b12]). [@b7] used PEG derivative containing carboxylic acid and lactose side chain (Lac-PEG-C) to deposit on the surface of DNA/protamine complex with positive charges, and then obtained 56-fold higher transfection efficiency with DNA/protamine/Lac-PEG-C at weight ratio 1:1.5:8 than that without Lac-PEG-C ([@b7]). Other researchers also made use of DNA/polycation complexes modified with PEG derivatives having carboxylic acid and/or sugar and received certain effects ([@b5], [@b4]). These DNA/polycation complexes modified with PEG derivatives showed a strong resistance against the albumin-induced aggregation and enhanced transfection efficiency compared to DNA/polycation complexes without modification. But in above investigations the amount of carboxylic acid and ligand in the line of PEG derivative was discrete, so didn't determine the amount of these molecules in PEG derivative. [@b1] linked peptide with negative charge such as INF7 or YE5C to glutamic acid on PEG-glutamice acid copolymer, then modified it on the surface of DNA complexes formed with PEI, PLL, or liposome, which obtained 2--20-folds higher efficiency than control. However there is a lot of interferon-7 (INF7) or YE5C in each PEG-glutamic acid copolymer in this approach. Although these peptide made PEG to closely adsorb on the surface of complex, these discrete peptide in each PEG-glutamic acid copolymer maybe cause some complexes to aggregate to large complexes even precipitation.

In our study, we showed a nonviral gene delivery system composed of PLL-, DNA-, and PLG-conjugated PEG or EGF. Here we used PLG as a bridge between DNA/PLL complex and PEG or EGF. There is one PEG or EGF conjugated to each PLG through sole end amino group of PLG. The advantage of this system is that each complex with various amounts of PEG and/or EGF can be produced easily without making a new synthesis, and PEG or EGF can maximally stand at the surface of complexes. Then we can adjust the amount of PEG or EGF in this system as long as controlling the amount of PLG. So we were able to conveniently investigate the relation between the amounts of PEG and/or EGF in complexes and physicochemical property or cell transfection efficiency of complexes.

Materials and methods
=====================

PLL (MW = 28, 500) was purchased from Sigma Chemical (St Louis, MO, USA) and used without further purification. Recombinant human EGF (rhEGF) was purchased from Shanghai Bioengineering center (Shanghai, China). PLG (20 glutamic acid, purity: ≥95%) was synthesized by Shanghai Sangon Biological Engineering Technology and Service Co., Ltd (Shanghai, China). Succinimidyl 4-\[N-maleimidomethyl\] cyclohexane-1-carboxylate (SMCC), N-succinimidyl 3-\[2-pyridyldithio\]-propionamido (SPDP) and slide-A-lyzer dialysis unit (3500, 10000 MWCO) were purchased from Pierce Biotechnology. Inc. (Rockford, IL, USA). sc-mPEG (MW = 5000, 10000, 20000, D = 1.12, sc cont: \>90%) were synthesized by Xinfeng Biotechnology Co., Ltd (Shanghai, China). Fused-silica capillary (75 μm ID) was purchased from Yongnian Optical Fiber Factory (Hebei, China). All other reagents were of analytical grade.

Cell culture
------------

Human hepatoma cell line SMMC-7721 (a gift from Shanghai Cancer Institute, Shanghai Jiaotong University, China) was cultured in DMEM supplemented with 10% fetal bovine serum (FBS) at 37 °C in 5% CO~2~ atmosphere.

Synthesis of PEG-g-PLG copolymers
---------------------------------

PEG-g-PLG was synthesized by coupling the amino group of PLG with various sc-mPEG as previously described ([@b2]) with small modification ([Scheme 1](#fig7){ref-type="fig"}). Briefly, PLG and sc-mPEG (at molar ratio of 6:1) were dissolved in 0.05 M phosphate buffer (pH 7.4) and DMSO respectively. sc-mPEG was added to the PLG solution quickly and the solution was stirred under N~2~ atmosphere at room temperature for 8 hours, then dialyzed against ultra-pure water in dialysis unit (3500 MWCO) twice for 3 h each.

![The schematic picture of PLG grafted with PEG.](ijn0302-249-07){#fig7}

Conjugation of PLG and EGF
--------------------------

Conjugation of PLG and EGF was referred to the method ([@b13]) with small modification ([Scheme 2](#fig8){ref-type="fig"}). Briefly, (1) 0.113 mg SPDP in DMSO was added to 1.5 mg EGF (the molar ratio of SPDP to EGF is 1.5:1) in phosphate buffers (pH 7.5) and quickly mixed. After reaction for 60 min at room temperature, the product was dialyzed against deionic water twice for 3 hr each by using dialysis unit (3500 MWCO), and then lyophilized for next procedure. (2) Lyophilized EGF-SPDP was redissolved in acetate acid buffer (pH 4.5), in which 1.84 mg 1, 4-Dithiothreitol (DTT) (the molar ratio of DTT to SPDP is 17:1) was added to activate the dithiol of SPDP on EGF-SPDP into sulphydryl group. After reaction for 30 min under N~2~ at room temperature, the product was dialyzed against deionic water twice for 3 h each by using dialysis unit (3500 MWCO), and then lyophilized for next procedure. (3) 0.8 mg SMCC in DMSO was added to 6.3 mg PLG (the molar ratio of SMCC to PLG is 0.8:1) in phosphate buffer (pH 7.4) and quickly mixed. After reacting for 60 min at room temperature, the product was ready for next procedure. (4) Lyophilized EGF-SPDP with sulphydryl group was dissolved in phosphate buffer (pH 7.4) and then added into PLG-SMCC solution under stirring. The mixture was incubated for 20 h at 10 degree celsius. After reaction, the product was dialyzed against deionic water twice for 3 h each by using dialysis unit (3500 MWCO) and then lyophilized.

![The schematic picture of PLG grafted with EGF.](ijn0302-249-08){#fig8}

Preparation of coated capillary
-------------------------------

The coated capillary in this study was prepared by our lab as previous described ([@b15]). Firstly capillary was washed by 0.1 M HCl, 0.1 M NaOH, and, water respectively. Then the inside wall of capillary was silanylated by 3-(trimethoxysilyl) propyl methacrylate. Finally the inside wall of capillary was coated by N, N-dimethylacrylamide. The coated capillary can be used after it has aged at room temperature overnight.

Characterization of PEG-g-PLG and EGF-g-PLG by capillary electrophoresis (CE)
-----------------------------------------------------------------------------

A P/ACE™ MDQ capillary electrophoresis system (Beckman, Fullerton, CA, USA) was equipped with the coated capillary (75 μm inner diameter). Samples were injected by pressure and the on column UV detection was set at 214 nm. The temperature of the capillary cartridge was maintained at 25 ± 0.1 °C.

Preparation of DNA/PLL/PLG conjugate complex
--------------------------------------------

PLL solution with concentration of 1 mg/ml (the total charge ratio of amino group in PLL to phosphate in DNA and carboxylic acid in PLG is 1:5, 1:3, 1:1, 3:1, or 5:1) was quickly mixed with 1 μg of pGL3 plasmid DNA with concentration of 1 mg/ml in HEPES buffer (pH 7.3, 10 mM) respectively and the mixture was incubated for 15 min at room temperature. Then PLG (or PEG-g-PLG, EGF-g-PLG) with concentration of 0.5 mg/ml (the charge ratio of phosphate in DNA to carboxylic acid in PLG is 1:5, 1:3, 1:1, 3:1, or 5:1) was incubated with DNA/PLL complex for 15 min at room temperature, respectively.

Size and zeta potential of DNA complex
--------------------------------------

The size and zeta potential of DNA and polymers complexes were measured by Photon Correlation Spectroscopy (PCS) (Malvern Instruments Ltd. Worcestershire, UK) equipped with a He-Ne laser of 633 nm. DNA and polymers complexes with different composition was injected into detector and measured at 25 °C with the constant angle of 90°.

Nuclease resistance of DNA complexes
------------------------------------

The ability of polymers to protect DNA from enzymatic degradation was evaluated by nuclease resistance assay as previous described ([@b6]). Briefly, 20 μl DNA complexes (1 μg DNA) were mixed with DNase I (1 unit/1 μg DNA) and the mixture was incubated for 20 min at 37 °C. Then the DNase I digestion was stopped by equal volume of stop solution (0.8 M NaCl, 50 mM EDTA) and 2 μl of 10% SDS was added to the mixture to disassociate DNA from the complexes at 65 °C overnight. DNA was extracted from the mixture by the phenol/chloroform solution and precipitated in 75% ethanol, then applied to 0.8% agarose gel electrophoresis.

Cell transfection assay
-----------------------

In vitro transfection efficiency of DNA complexes was tested in SMMC-7721 cells. Complexes containing 1 μg DNA were added into each well in the medium supplemented with or without 10% FBS. After incubating for 6 hr, medium with complexes was removed and substituted by 0.5 ml medium with 10% FBS. Cells were incubated for another 42 h. At the end of incubation, medium was removed and 200 μl of lysis buffer was added into each well to disassociate cells from plate. The lysed cells were collected and spun down. 50 μl of supernatant were mixed with 50 μl of luciferase reagent (Promega Corp, Wisconsin, USA), the luminescence value were detected by the TD-20/20 luminometer (Turnerbiosystems Inc, California, USA).

Results and discussions
=======================

Characterization of PEG-g-PLG and EGF-g-PLG
-------------------------------------------

When PLG was linked to PEG of various lengths, peak position of PEG-g-PLG was obviously different when running in CE ([Figure 1A](#fig1){ref-type="fig"}). The longer the length of PEG, the shorter the peak time of PEG-g-PLG was. The peaks of PLG, EGF-g-PLG and EGF were approximately appeared at 5th min, 22nd min, and 29th min, respectively ([Figure 1B](#fig1){ref-type="fig"}).

![(**A**) The electropherogram of PLG (a), PEG~5000~-g-PLG (b), PEG~10000~-g-PLG (c), PEG~20000~-g-h (the wavelength of 214 nm); coated capillary with a effective length of 50 cm, 75 μm I.D; phosphated buffer of 30 mM, pH 8.5; injected at 0.5psi for 5 sec; separated at −10 kv. (**B**) The electropherogram of PLG (a), EGF-g-PLG (b), EGF (c). Running conditions: UV detection (the wavelength of 214 nm); coated capillary with a effective length of 50 cm, 75 μm I.D; phosphated buffer of 40 mM, pH 8.0; injected at 0.5psi for 5 sec; separated at −10 kv.](ijn0302-249-01){#fig1}

Size and zeta potential of DNA complex
--------------------------------------

The size of complex gradually increased from about 58 nm, which was the size of DNA/PLL, when PEG-g-PLG was added at PLG to DNA charge ratio below 1 ([Figure 2A](#fig2){ref-type="fig"}). At the PLG to DNA charge ratio of 1, the largest size of complex containing PEG~5000~-g-PLG, PEG~10000~-g-PLG or PEG~20000~-g-PLG was about 78, 83, and 88 nm, respectively. Meanwhile the polydispersity index of these complexes, which was at the ranges of 0.19 to 0.29, didn't obviously change ([Figure 2C](#fig2){ref-type="fig"}). So it was believed that the addition of PEG-g-PLG to DNA/PLL didn't lead to aggregate. In comparison, aggregation was observed by adding PLG alone in DNA/PLL complex (data not shown). The size of complex was correlated with the molecular weight of PEG-g-PLG, ie, the size of complex containing PEG~20000~-g-PLG is larger than the size of complex containing PEG~10000~-g-PLG, which is larger than the size of complex containing PEG~5000~-g-PLG ([Figure 2B](#fig2){ref-type="fig"}). At PLG to DNA ratio below 1, the size of complexes containing PEG~20000~-g-PLG, PEG~10000~-g-PLG or PEG~5000~-g-PLG increased to 88 nm, 77 nm, and 71 nm, respectively. At the same time the polydispersity index of complexes at about 0.22 didn't obviously change ([Figure 2D](#fig2){ref-type="fig"}). It was believed that the addition of PEG-g-PLG did not lead to aggregation of complexes. When PLG to DNA charge ratio in complex was more than 1, further increase this ratio resulted in decrease of the complex size ([Figure 2B](#fig2){ref-type="fig"}). Meanwhile the polydispersity index of complexes gradually increased at PLG to DNA charge ratio above 1 ([Figure 2D](#fig2){ref-type="fig"}). This might be due to the binding of some PEG-g-PLG and excessive free PLL leading to formed smaller complex, so that the average size of complexes decreased and the polydispersity index of complexes increased at PLG to DNA charge ratio above 1.

![The size (**A**) and polydispersity index (**C**) of DNA/PLL complexes formed with increasing the amount of PEG~5000~-g-PLG (♦), PEG~10000~-g-PLG (■) and PEG~20000~-g-PLG (▲) at N/P ratio of 2 res pectively. The size (**B**) and polydispersity index (**D**) of DNA/PLL complexes formed with PEG~5000~-g-PLG (♦), PEG~10000~-g-PLG (■) and PEG~20000~-g-PLG (▲) at total positive to negative charge ratio of 1 respectively.](ijn0302-249-02){#fig2}

The δ-potential of complex containing PLG gradually decreased with increasing the amount of PLG in complex until PLG to DNA charge ratio of 2, at which ratio the δ-potential was about -30 mV ([Figure 3A](#fig3){ref-type="fig"}). It was believed that PLG was bind to DNA/PLL complex. This result was in agreement with the previous observations by [@b11] and [@b1], in which polyelectrolytes with negative charge could be attached to the surface of condensed DNA particles and obviously decreased the zeta-potential of complexes. [@b11] have observed that at the charge stoichiometry of DNA/PLL/SPLL close to 1:1:1 negative charge SPLL can form tertiary complexes with binary DNA/PLL complexes and make the complexes negative. Meanwhile adding PEG-g-PLG into DNA/PLL complex resulted in successfully shielding the δ-potential of complex at the PLG to DNA ratio above 1 ([Figure 3A](#fig3){ref-type="fig"}). If adding excessive PLL into the complex, ie, the total positive charge to negative charge ratio is more than 1, it was shown that the δ-potential of complex containing PEG~20000~-g-PLG or PEG~10000~-g-PLG obviously was lower than that containing PEG~5000~-g-PLG. Below this ratio, the δ-potential of complex formed with different molecule weight of PEG-g-PLG didn't differ from each other ([Figure 3B](#fig3){ref-type="fig"}).

![(**A**) Zeta potential of complexes containing PLG (♦), PEG~5000~-g-PLG (●), PEG~10000~-g-PLG (▲) and PEG~20000~-g-PLG (■) respectively with the PLG to DNA charge ratio at the N/P ratio of 2. (**B**) Zeta potential of complexes containing PEG~5000~-g-PLG (■), PEG~10000~-g-PLG (●) and PEG~20000~-g-PLG (▲) respectively with total positive to negative charge ratio at the PLG to DNA charge ratio of 1.](ijn0302-249-03){#fig3}

Nuclease resistance of DNA complexes
------------------------------------

One concern of this system was that polyanion may dissociate DNA complexes by competing with DNA for binding to the polycation ([@b11]). Another concern was whether PLG or PEG-g-PLG could substitute DNA from complexes or not. It has been shown that DNA could be released from the complexes by adding certain amount of polyanion to the complexes ([@b3]; [@b5]). Here it was shown that complexes containing PEG~20000~-g-PLG or PEG~10000~-g-PLG had stronger protection ability, in which DNA was not or a little digested by DNase I, than complexes containing PEG~5000~-g-PLG at positive to negative charge ratio of 1 ([Figure 4](#fig4){ref-type="fig"}). This was probably due to the formation of PEG palisade surrounding the ion-complex core of DNA and PLL segment of the block copolymer ([@b3]).

![The effect of different molecular PEG-g-PLG on the resistance of complex to the digestion of DNase I at N/P ratio of 2 and the PLG to DNA charge ratio of 1. 1. marker, 2. DNA, 3. PEG~5000~-g-PLG, 4. PEG~10000~-g-PLG and 5. PEG~20000~-g-PLG.](ijn0302-249-04){#fig4}

Cell transfection assay
-----------------------

At total positive to negative charge ratio below 1, the transfection efficiency of complex was similar to control ([Figure 5A](#fig5){ref-type="fig"}), because when the charge amount of PLL was fewer than that of DNA, PEG~20000~-g-PLG and EGF hardly attached to the surface of complexes with negative charge. Meanwhile at total positive to negative charge ratio of 1, the complex showed the maximum transfection efficiency which was about 10 times that of control. In comparison, at total positive to negative charge ratio of 3 and 5, the transfection efficiency gradually decreased. This was due to that when the charge amount of PLL was more than that of DNA, PEG~20000~-g-PLG and EGF-g-PLG could adsorb to both DNA/PLL complexes and excess PLL. This is the similar to the transfection results with different charge ratio of DNA to PLG at total positive to negative charge ratio of 1 ([Figure 6B](#fig6){ref-type="fig"}). Surplus PLL could competitively bind with PEG~20000~-g-PLG and EGF-g-PLG, because PLG was added into DNA/PLL complexes after DNA and PLL was mixed to form complexes, although the charge amount of PLL was equal to that of DNA and PLG.

![(**A**) The transfection efficiency of complexes containing PEG~20000~-g-PLG and EGF-g-PLG with total positive to negative charge ratio at the presence of serum. (**B**) The transfection efficiency of complexes containing PLG conjugated different length of PEG at the presence (■) or absence (□) of serum.](ijn0302-249-05){#fig5}

![(**A**) The transfection of complexes formed with different component at the presence (■) or absence (□) of serum. (**B**) The transfection efficiency of complexes with different amount of PEG~20000~-g-PLG and EGF-g-PLG at N/P ratio of 2 and the presence of serum.](ijn0302-249-06){#fig6}

The transfection efficiency of complexes containing PEG~5000~-g-PLG was lower than complexes containing other length of PEG-g-PLG at the presence or absence of serum ([Figure 5B](#fig5){ref-type="fig"}), in which the transfection efficiency of complexes containing PEG~10000~-g-PLG or PEG~20000~-g-PLG was about 20 to 25 times higher than control, probably because enzyme in cell could digest DNA without or with little protection. This was consistent with the result obtained from the assay of DNase I digestion in which complexes containing PEG~5000~-g-PLG have the worst resistance to DNase I among these complexes ([Figure 4](#fig4){ref-type="fig"}). Only EGF on the surface of complexes could obviously increase the transfection efficiency of complexes which was higher than both PEG~20000~-g-PLG and EGF-g-PLG added into complexes in the medium without serum ([Figure 6A](#fig6){ref-type="fig"}). This was probably because the binding of EGF with EGFR on cell was influenced by the steric effect of PEG~20000~-g-PLG. But at medium with serum PEG~20000~-g-PLG could protect complexes from attacking of protein in serum, so the transfection efficiency of complexes containing PEG~20000~-g-PLG and EGF-g-PLG was higher than complexes only containing EGF-g-PLG at this condition.

Conclusions
===========

In summary, we presented a novel modification method for gene delivery system in which PLG was used as surface modification loading backbone, to which PEG or EGF was linked, to form complexes with PLL and DNA. This system possessed an appreciable advantage of modulating the amount of PEG and/or targeting peptide on the surface of complexes without the need to synthesize a new copolymer containing PEG and/or targeting peptide for each formulation. By using this method, it should be possible to determine the correlation between biological property or physicochemical property of complexes and the amount of PEG and/or targeting peptide in complexes and determine the best complex with optimal transfection efficiency. Although this system provided certain enhancement in cell transfection efficiency, some modification on this system should be taken. For example excessive PLL in DNA/PLL complexes had better be removed to decrease the effect of excessive PLL on the adsorption of PLG conjugates to the surface of DNA/PLL complexes.
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